Blue Rock Wealth Management’s Pfizer PFE Stock Holding History

Blue Rock Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Hold	16,416	–	–	0.22%	63
2026 Q1	$464K	Buy	16,416 +707	+5%	+$18.8K	0.3%	54
2025 Q4	$395K	Buy	15,709 +2,000	+15%	+$50.4K	0.25%	63
2025 Q3	$353K	Buy	13,709 +1,000	+8%	+$24.7K	0.22%	71
2025 Q2	$312K	Hold	12,709	–	–	0.22%	72
2025 Q1	$325K	Buy	+12,709	New	+$333K	0.28%	66

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Blue Rock Wealth Management's PFE Position: Q2 2026 in Review

Blue Rock Wealth Management held its Pfizer (PFE) position steady in Q2 2026 at 16,416 shares worth $399K. The position accounts for 0.22% of the portfolio, ranked #63.

Blue Rock Wealth Management first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $464K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Blue Rock Wealth Management held 16,416 shares of Pfizer worth $399K as of Q2 2026.
Blue Rock Wealth Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.22% of Blue Rock Wealth Management's portfolio in Q2 2026, its #63 holding.
Blue Rock Wealth Management first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
Blue Rock Wealth Management's Pfizer position peaked at $464K in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blue Rock Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.